High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$6.2M
$6,190,904
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-03-02 | $286,715 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -23.1%
2025-12-05
$168,997
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -23.1%
|
2025-12-05 | $168,997 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -12.9%
2025-12-05
$74,445
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -12.9%
|
2025-12-05 | $74,445 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-05
$31,456
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-05 | $31,456 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
2025-12-05
$62,346
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
|
2025-12-05 | $62,346 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-05
$52,416
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-05 | $52,416 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-12-05 | $15,923 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-05 | $199,481 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-12-05 | $52,358 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-04
$6,075
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-04 | $6,075 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-04 | $160,647 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-04 | $38,550 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-04
$42,238
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-04 | $42,238 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-04
$10,115
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-04 | $10,115 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-04
$25,349
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-04 | $25,349 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-03
$27,244
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-03 | $27,244 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-03 | $0 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-03
$23,937
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-03 | $23,937 | S | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Equity Compensation
2025-12-03
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Equity Compensation
|
2025-12-03 | $0 | M | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
2025-12-03
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
|
2025-12-03 | $0 | M | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-03 | $12,712 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-03
$37,788
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-03 | $37,788 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-03
$43,002
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-03 | $43,002 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-03 | $20,082 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-02 | $19,540 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-02 | $12,207 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-02
$41,860
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-02 | $41,860 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-02
$22,968
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-02 | $22,968 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-02
$36,775
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-02 | $36,775 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-02
$26,163
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-02 | $26,163 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Equity Compensation
2025-12-01
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
2025-12-01
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Krainer Adrian R.
• Director
10b5-1 SellΔOwn -11.1%
2025-11-24
$1,202,719Large
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -11.1%
|
2025-11-24 | $1,202,719Large | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-11-14 | $526,693 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-11-14 | $565,365 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
2025-11-03
$2,935
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
|
2025-11-03 | $2,935 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
2025-11-03
$16,524
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
|
2025-11-03 | $16,524 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -28.8%
2025-11-03
$95,247
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -28.8%
|
2025-11-03 | $95,247 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -15.6%
2025-11-03
$37,860
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -15.6%
|
2025-11-03 | $37,860 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Other
|
2025-10-08 | $15,000 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Kaye Edward M. MD
• Director
10b5-1 SellΔOwn -33.7%
2025-10-08
$750,000
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -33.7%
|
2025-10-08 | $750,000 | S | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Other
2025-10-03
$91,500
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Other
|
2025-10-03 | $91,500 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -45.8%
2025-10-03
$250,650
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -45.8%
|
2025-10-03 | $250,650 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Kaye Edward M. MD
• Director
10b5-1 SellΔOwn -46.4%
2025-10-03
$1,065,206Large
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -46.4%
|
2025-10-03 | $1,065,206Large | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -28.9%
2025-10-01
$126,316
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -28.9%
|
2025-10-01 | $126,316 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Equity Compensation
|
2024-12-01 | $0 | M | Form 4 |